CA2176557C - Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3 - Google Patents

Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3 Download PDF

Info

Publication number
CA2176557C
CA2176557C CA002176557A CA2176557A CA2176557C CA 2176557 C CA2176557 C CA 2176557C CA 002176557 A CA002176557 A CA 002176557A CA 2176557 A CA2176557 A CA 2176557A CA 2176557 C CA2176557 C CA 2176557C
Authority
CA
Canada
Prior art keywords
compound
groups
formula
group
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002176557A
Other languages
English (en)
Other versions
CA2176557A1 (fr
Inventor
Robert G. Aslanian
Michael J. Green
Neng-Yang Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority claimed from PCT/US1994/012717 external-priority patent/WO1995014007A1/fr
Publication of CA2176557A1 publication Critical patent/CA2176557A1/fr
Application granted granted Critical
Publication of CA2176557C publication Critical patent/CA2176557C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention se rapporte à des nouveaux phényl-alkyl-imidazoles de formule (I) ainsi qu'à leurs sels pharmaceutiquement acceptables. Dans cette formule, A, R?1¿, R?2¿, m et n sont tels que définis dans la description de l'invention, et le groupe —(CH¿2?)¿n?—A—R?1¿ est en position 3 ou 4. Ces phényl-alkyl-imidazoles ainsi que leurs sels ont des propriétés pharmacologiques précieuses, notamment un effet sur le système nerveux central et une activité contre les maladies inflammatoires.
CA002176557A 1993-11-15 1994-11-10 Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3 Expired - Fee Related CA2176557C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15323193A 1993-11-15 1993-11-15
US08/153,231 1993-11-15
PCT/US1994/012717 WO1995014007A1 (fr) 1993-11-15 1994-11-10 Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3

Publications (2)

Publication Number Publication Date
CA2176557A1 CA2176557A1 (fr) 1995-05-26
CA2176557C true CA2176557C (fr) 2006-03-14

Family

ID=36095683

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176557A Expired - Fee Related CA2176557C (fr) 1993-11-15 1994-11-10 Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3

Country Status (1)

Country Link
CA (1) CA2176557C (fr)

Also Published As

Publication number Publication date
CA2176557A1 (fr) 1995-05-26

Similar Documents

Publication Publication Date Title
EP0729459B1 (fr) Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3
US5411971A (en) N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions
US6248901B1 (en) Heterocyclic vinyl ethers
EP0821674B1 (fr) Agents amidino cycliques utiles en tant qu'inhibiteurs de synthase de l'oxyde nitrique
JP4177435B2 (ja) 治療薬
PT1438296E (pt) Derivados de 1h-imidazol possuindo actividade agonística cb1, antagonista parcial cb1 ou antagonista cb1
RU2136676C1 (ru) Производное бензимидазола, фармацевтический состав и способ модуляции гамкa - рецепторного комплекса
JP2001502712A (ja) 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
US6034251A (en) Phenyl-alkyl-imidazoles
EP1028948B1 (fr) Phenyl-alkyl-imidazoles utilises comme antagonistes du recepteur h 3?
US7524867B2 (en) Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
EP1756066B1 (fr) Derives d'imidazole tetrasubstitues utilises comme modulateurs du recepteur des cannabinoides cb1 a activite de selectivite de sous-types du recepteur cb1/cb2 elevee
CA2176557C (fr) Phenyl-alkyl-imidazoles servant d'antagonistes du recepteur de h3
WO2001044207A2 (fr) Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
EP1675833B1 (fr) Derives de 1h-imidazole comme modulateurs du recepteur de cannabinoides
AU1296699A (en) H3 receptor ligands of the phenyl-alkyl-imidazoles type
US20070281974A1 (en) 1 h-imidazole derivatives as cannabinoid receptor modulators
EP1318983B1 (fr) Imidazoles substituees utiles en tant qu'agonistes ou qu'antagonistes de l'histamine h1 et/ou h3
EP0500348B1 (fr) Urées et thiurées disubstituées
EP0153746B1 (fr) Dérivés 3-amino-2-hydroxypropyl de pyrimidine-4-one
HU216843B (hu) Szubsztituált piridiniumsók, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
MXPA00004433A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
MXPA06011243A (en) Therapeutic agents
TW200406391A (en) 1H-1,2,4-Triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed